News Bell: New York & Company, Inc. (NYSE:NWY), Check-Cap Ltd. (NASDAQ:CHEK)

0

New York & Company, Inc. (NYSE:NWY)

No Records Found

In the last Quarter, New York & Company, Inc. (NYSE:NWY) reported its Actual EPS of $0.05/share. The analysts offering Earnings Estimates for the company were believing that New York & Company, Inc. could bring EPS of $0.02/share. The difference between Actual EPS and Estimated EPS was 0.03 Percent. Thus showing an Earnings Surprise of 150 Percent.

Check-Cap Ltd. (NASDAQ:CHEK)

In the last trading session, Check-Cap Ltd. (NASDAQ:CHEK) added its value by 0% closing at the price of $3.29. The stock currently has market capitalization of 17.62 Million, with average volume of 78.69 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Check-Cap Ltd. (NASDAQ:CHEK) is showing beta of -0.15. This particular value of beta suggests that Check-Cap Ltd. (NASDAQ:CHEK) has historically moved -15% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Check-Cap Ltd. (NASDAQ:CHEK) is at $-3.69.

The stock currently has RSI of 41.93. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel.

Check-Cap Ltd. (NASDAQ:CHEK) topped its 52-week high price of $19.78 on 04/25/18 and 52-Week Low Price of $ 3.08 on 08/10/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 5.39% and monthly volatility of 7.42% respectively.